BPI-ANCA is found in reactive arthritis caused by Yersinia and Salmonella infection and recognise exclusively the C-terminal part of the BPI molecule

Scandinavian Journal of Rheumatology

Volumn 29, Issue 4, 2000, Pages 226-231

  Schultz, H ^a   Csernok, E ^a   Nikkari, S ^a   Toivanen, P ^a   Toivanen, A ^a   Gross, W L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

ANCA; Bactericidal permeability increasing protein; Reactive arthritis

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; HYBRID PROTEIN; LIPOPOLYSACCHARIDE BINDING PROTEIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BINDING SITE; CARBOXY TERMINAL SEQUENCE; DIAGNOSTIC VALUE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REACTIVE ARTHRITIS; SALMONELLA; YERSINIA;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIMICROBIAL CATIONIC PEPTIDES; ARTHRITIS, REACTIVE; BLOOD BACTERICIDAL ACTIVITY; BLOOD PROTEINS; CARRIER PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GOATS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; NEUTRALIZATION TESTS; SALMONELLA INFECTIONS; YERSINIA INFECTIONS;

EID: 0034538880     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097400750041361     Document Type: Article

References (18)

1. Reactive arthritis
2. Antineutrophil cytoplasmic antibodies directed against bactericidal/permeability increasing protein (BPI): A new seromarker for inflammatory bowel disease and associated disorders
3. The bactericidal/permeability increasing in anti-bacterial host defense
4. The evolution of spondylarthropathies in relation to gut histology. III Relation between gut and joint
5. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy
6. The value of indirect immunofluorescence and solid phase techniques for ANCA detection: A report on the first phase of an international cooperative study on the standardization of ANCA assays
7. Use of native and recombinant bactericidal/permeability increasing protein (BPI) as antigens for detection of BPI-ANCA
8. Biochemical characterisation of recombinant fusions of lipopolysaccharide binding protein and bactericidal/permeability increasing protein
9. A monoclonal antibody that inhibits the antimicrobial action of a 57 kD cationic protein of human polymorph-nuclear leukocytes
10. Characterization of two monoclonal antibodies directed against bactericidal/permeability increasing protein
11. Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p 15s in an evolving sterile rabbit peritoneal inflammatory exsudate
12. Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis
13. Are antineutrophil cytoplasmic antibodies of immunodiagnostic value in reactive arthritis?
14. Inflammatory bowel disease is associated with increased mucosal levels of Bactericidal/ permeability increasing protein
15. An opsonic function of the neutrophil bactericidal/permeability increasing protein depends on both its N- and C-terminal domains
16. Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease
17. Ulcerative colitis - Like disease in mice with a disrupted interleukin - 2 gene
18. pANCA represents a cross-reactivity to enteric bacterial antigens